Cargando…
Leveraging a powerful allogeneic dendritic cell line towards neoantigen-based cancer vaccines
In recent years, immunotherapy has finally found its place in the anti-cancer therapeutic arsenal, even becoming standard of care as first line treatment for metastatic forms. The clinical benefit provided by checkpoint blockers such as anti-PD-1/PD-L1 in many cancers revolutionized the field. Howev...
Autores principales: | Hannani, Dalil, Leplus, Estelle, Laulagnier, Karine, Chaperot, Laurence, Plumas, Joël |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886307/ https://www.ncbi.nlm.nih.gov/pubmed/36726965 http://dx.doi.org/10.18632/genesandcancer.229 |
Ejemplares similares
-
A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients
por: Hannani, Dalil, et al.
Publicado: (2023) -
Photopheresis efficacy in the treatment of rheumatoid arthritis: a pre-clinical proof of concept
por: Coppard, Céline, et al.
Publicado: (2019) -
Engineering a Human Plasmacytoid Dendritic Cell-Based Vaccine to Prime and Expand Multispecific Viral and Tumor Antigen-Specific T-Cells
por: Lenogue, Kevin, et al.
Publicado: (2021) -
A Novel Cancer Vaccine Strategy Based on HLA-A*0201 Matched Allogeneic Plasmacytoid Dendritic Cells
por: Aspord, Caroline, et al.
Publicado: (2010) -
An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial
por: Charles, Julie, et al.
Publicado: (2020)